Most importantly, the presence of miR-NRF2 in malignant cells significantly increased the survival of GBM-bearing mice compared with controls (Fig. 6i), an effect that was more marked than upon the partial removal of p16Ink4a Hi senescent cells (Figs. 2c, d, and 6i). Here, CDKN2A is linked to glioblastoma.